findmyKOL
Clinical trialNCT03137797CompletedObservational

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

SponsorANRS, Emerging Infectious DiseasesEnrollment800HIV Infection
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the short, medium and long-term prognosis for newly diagnosed HIV patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Laurence Meyer, Professor

    Institut National de la Santé Et de la Recherche Médicale, France

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Meyer

    Le Kremlin-Bicêtre, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Feb 2004
Primary completion
30 Jun 2016
Completion
30 Jun 2016
Last update posted
3 May 2017
Registered enrollment
800
Registry id
NCT03137797

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.